Article Details

Celltrion Gains Canadian Nod for Subcutaneous Infliximab

Retrieved on: 2021-02-05 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

Celltrion Gains Canadian Nod for Subcutaneous Infliximab. View article details on hiswai:

Excerpt

“We are proud that Remsima SC will be the first product to enter the Canadian market under our new direct sales marketing strategy. We plan to ...

Article found on: www.centerforbiosimilars.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo